EUVIMEDEUVIMED entdecken
Crossref

Self-Nanoemulsifying Formulation Improves Oral Bioavailability and Insulin Sensitizing Potency of Formononetin–Vitamin E Conjugate in Type 2 Diabetic Mice

Rakesh Kumar Dhritlahre, Navneet Thakur, Abhishek Goel, Vikram Patial iD, Yogendra Padwad iD, Ankit Saneja iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c00886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Rakesh Kumar Dhritlahre und 5 weiteren Autor:innen. Beteiligte Einrichtung: Formulation Laboratory, Dietetics & Nutrition Technology Division, CSIR - Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 1…. Hauptthemen laut MEDLINE: Isoflavones, Biological Availability, Rats, Sprague-Dawley, Emulsions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission, Academy of Scientific and Innovative Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating incidence of obesity, diabetes, and insulin resistance has become a significant global health concern. In this study, we have developed a self-nanoemulsifying delivery system (SNEDS) of formononetin-vitamin E conjugate (VESylated-FMN) for improving its oral bioavailability and improving insulin sensitivity and glycemic control. The developed SNEDS were characterized using dynamic light scattering and transmission electron microscopy. Thereafter, the loading capacity, in vitro release, thermodynamic, and gastrointestinal stability of the developed formulation were evaluated. The safety and oral bioavailability of VESylated-FMN-SNEDS were assessed in Sprague-Dawley rats, whereas insulin-sensitizing potency was assessed in high-fat diet-induced type 2 diabetic mice. The VESylated-FMN-SNEDS quickly emulsified on dilution (droplet size ∼79.17 nm) and showed remarkable thermodynamic and gastrointestinal stability. The developed formulation demonstrated enhanced oral bioavailability (∼1.3-fold higher AUC0-t) of VESylated-FMN without liver and kidney injury. Consequently, VESylated-FMN-SNEDS significantly improves insulin sensitivity and glycemic control in HFD-fed mice compared to VESylated-FMN by upregulating the transcript level of insulin-sensitizing genes. Therefore, the SNEDS formulation could be an effective strategy to augment the oral bioavailability and insulin-sensitizing potency of VESylated-FMN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesBiological AvailabilityRats, Sprague-DawleyEmulsionsDiabetes Mellitus, Type 2Insulin ResistanceVitamin EAnimalsMiceMaleRatsAdministration, OralDiet, High-FatDiabetes Mellitus, ExperimentalInsulinHypoglycemic AgentsNanoparticlesMice, Inbred C57BL

Stichwörter der Autor:innen

VESylated-FMNVESylated-FMN-SNEDSbioavailabilityhigh-fat dietinsulin sensitivitytype 2 diabetes

Substanzen

IsoflavonesEmulsionsformononetinVitamin EInsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Formulation Laboratory, Dietetics & Nutrition Technology Division, CSIR - Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176061, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India.
  • Pharmacology and Toxicology Laboratory, Dietetics & Nutrition Technology Division, CSIR - Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176061, India.

ORCID-Profile: Vikram Patial, Yogendra Padwad, Ankit Saneja

Förderung

  • Council of Scientific and Industrial Research, India
  • University Grants Commission
  • Academy of Scientific and Innovative Research

Zitieren

APA

Dhritlahre, R. K., Thakur, N., Goel, A., Patial, V., Padwad, Y., & Saneja, A. (2025). Self-Nanoemulsifying Formulation Improves Oral Bioavailability and Insulin Sensitizing Potency of Formononetin–Vitamin E Conjugate in Type 2 Diabetic Mice. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00886

Vancouver

Dhritlahre RK, Thakur N, Goel A, Patial V, Padwad Y, Saneja A. Self-Nanoemulsifying Formulation Improves Oral Bioavailability and Insulin Sensitizing Potency of Formononetin–Vitamin E Conjugate in Type 2 Diabetic Mice. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c00886

BibTeX
@article{Dhritlahre2025,
  author = {Dhritlahre, Rakesh Kumar and Thakur, Navneet and Goel, Abhishek and Patial, Vikram and Padwad, Yogendra and Saneja, Ankit},
  title = {Self-Nanoemulsifying Formulation Improves Oral Bioavailability and Insulin Sensitizing Potency of Formononetin–Vitamin E Conjugate in Type 2 Diabetic Mice},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c00886}
}
Kostenlos starten →